CUSIP: 78464A391
Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / BLOOMBERG EMERGI
-
Total 13F shares
-
24,552,329
-
Share change
-
+2,121,360
-
Total reported value
-
$683,114,016
-
Price per share
-
$27.82
-
Number of holders
-
74
-
Value change
-
+$59,300,544
-
Number of buys
-
38
-
Number of sells
-
37
Security key
78464A391
Report period
Q2 2019
Institutions
74
Top holders
10
Reporting periods
Holder history for CUSIP 78464A391
Recent filing periods:
Top shareholders of EBND - SPDR SERIES TRUST - BLOOMBERG EMERGI (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.
Institutional Holders of SPDR SERIES TRUST - BLOOMBERG EMERGI (EBND) as of Q2 2019
As of 30 Jun 2019,
SPDR SERIES TRUST - BLOOMBERG EMERGI (EBND) was held by
74 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
24,552,329 shares.
The largest 10 holders included
Charles Schwab Investment Advisory, Inc., Choate Investment Advisors, TD AMERITRADE INVESTMENT MANAGEMENT, LLC, WEALTH ENHANCEMENT ADVISORY SERVICES, LLC, ASSETMARK, INC, MERCER GLOBAL ADVISORS INC /ADV, CREDIT SUISSE AG/, WELLS FARGO & COMPANY/MN, CI INVESTMENTS INC., and Global Financial Private Capital, LLC.
This page lists
74
institutional shareholders reporting positions in this security
for the Q2 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
Compare Q2 2019 vs Q1 2019 Across Filers
| Investor |
Q1 2019 Shares |
Q2 2019 Shares |
Share Diff |
Share Chg % |
Q1 2019 Value $ |
Q2 2019 Value $ |
Value Diff $ |
Value Chg % |
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.